Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimer's Disease
Author
dc.contributor.author
Rojo, Leonel E.
Author
dc.contributor.author
Fernández, Jorge A.
Author
dc.contributor.author
Maccioni, Andrea A.
Author
dc.contributor.author
Jiménez, José M.
Author
dc.contributor.author
Maccioni Baraona, Ricardo
Admission date
dc.date.accessioned
2019-03-11T12:55:02Z
Available date
dc.date.available
2019-03-11T12:55:02Z
Publication date
dc.date.issued
2008
Cita de ítem
dc.identifier.citation
Archives of Medical Research, Volumen 39, Issue 1, 2018, Pages 1-16
Identifier
dc.identifier.issn
01884409
Identifier
dc.identifier.other
10.1016/j.arcmed.2007.10.001
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/164439
Abstract
dc.description.abstract
During the past few years, an increasing set of evidence has supported the major role of deregulation of the interaction patterns between glial cells and neurons in the pathway toward neuronal degeneration. Neurons and glial cells, together with brain vessels, constitute an integrated system for brain function. Inflammation is a process related with the onset of several neurodegenerative disorders, including Alzheimer's disease (AD). Several hypotheses have been postulated to explain the pathogenesis of AD, but none provides insight into the early events that trigger metabolic and cellular alterations in neuronal degeneration. The amyloid hypothesis was sustained on the basis that Aβ-peptide deposition into senile plaques is responsible for neurodegeneration. However, recent findings point to Aβ oligomers as responsible for synaptic impairment in neuronal degeneration. Amyloid is only one among many other major factors affecting the quality of neuronal cells. Another explanation derive